Literature DB >> 25895991

[Antisynthetase syndrome with pulmonary hypertension: 4 original observations].

R Lecomte1, F Perrin1, L Journeau1, O Espitia1, N Piriou2, D Horeau-Langlard3, A Néel1, A Masseau1, M Hamidou1, C Agard4.   

Abstract

INTRODUCTION: Pulmonary hypertension (PH) may occur in patients with antisynthetase syndrome (ASS) but this association is poorly studied. In this article, we report 4 new cases of PH associated with ASS, and we discuss PH mechanisms in this specific disease. CASES: Four patients (3 females, 1 male) with confirmed ASS associated with anti-Jo1 (n=3), anti-PL7 (n=1), and anti-Ro52 (n=3) antibodies were analyzed. They presented with subacute dyspnea in average ten years after they were first diagnosed as ASS. Diagnosis of pre-capillary PH was made (mean of mPAP: 34mmHg): PAH (n=1), group 3 PH (n=2) and PH associated to hyperthyroidism (n=1). Among three patients who received specific PAH therapy, two had significant improvement in both clinical and hemodynamic parameters.
CONCLUSION: During ASS, PH may occur in 5 to 10 % of cases, caused by various mechanisms. Unexplained dyspnea may be due to PH among ASS patients.
Copyright © 2015 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Anti-tRNA-synthetase antibody; Anticorps antiARNt synthétase; Antisynthetase syndrome; Hypertension artérielle pulmonaire; Hypertension pulmonaire; Pulmonary arterial hypertension; Pulmonary hypertension; Syndrome des antisynthétases

Mesh:

Year:  2015        PMID: 25895991     DOI: 10.1016/j.revmed.2015.03.013

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Antisynthetase syndrome with rare EJ-1 antibodies with antiphospholipid syndrome.

Authors:  Louis Chhor; Steven Tu; Paul Fogarty; Christopher Fong
Journal:  Respirol Case Rep       Date:  2022-06-13

2.  Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis-Scleroderma Overlap Cohort.

Authors:  Katalin Szabó; Levente Bodoki; Melinda Nagy-Vincze; Tibor Béldi; Anett Vincze; Erika Zilahi; József Varga; Gabriella Szűcs; Katalin Dankó; Zoltán Griger
Journal:  Biomed Res Int       Date:  2022-05-02       Impact factor: 3.246

Review 3.  Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.

Authors:  Sébastien Sanges; Cécile M Yelnik; Olivier Sitbon; Olivier Benveniste; Kuberaka Mariampillai; Mathilde Phillips-Houlbracq; Christophe Pison; Christophe Deligny; Jocelyn Inamo; Vincent Cottin; Luc Mouthon; David Launay; Marc Lambert; Pierre-Yves Hatron; Laurence Rottat; Marc Humbert; Eric Hachulla
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.